Emerging research suggest Retatrutide , a dual stimulator targeting both GLP-1 and GIP , may offer a notable development for weight management . Preliminary patient investigations have shown substantial reductions in visceral tissue, conceivably surpassing current obesity medications . Despite this, additional study is needed to fully determine … Read More